Copyright Reports & Markets. All rights reserved.

Global Beef Cattle Vaccine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Beef Cattle Vaccine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Beef Cattle Vaccine by Type
    • 1.3.1 Overview: Global Beef Cattle Vaccine Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Beef Cattle Vaccine Consumption Value Market Share by Type in 2022
    • 1.3.3 Inactivated Foot and Mouth Disease Vaccine
    • 1.3.4 Bacillus Anthracis Vaccine
    • 1.3.5 Clostridium Botulinum Vaccine
    • 1.3.6 Brucella Vaccine
    • 1.3.7 Pasteurella Vaccine
    • 1.3.8 Bovine Rotavirus Vaccine
    • 1.3.9 Others
  • 1.4 Global Beef Cattle Vaccine Market by Application
    • 1.4.1 Overview: Global Beef Cattle Vaccine Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Grass Fed Beef Cattle
    • 1.4.3 Grain-Fed Beef Cattle
  • 1.5 Global Beef Cattle Vaccine Market Size & Forecast
  • 1.6 Global Beef Cattle Vaccine Market Size and Forecast by Region
    • 1.6.1 Global Beef Cattle Vaccine Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Beef Cattle Vaccine Market Size by Region, (2018-2029)
    • 1.6.3 North America Beef Cattle Vaccine Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Beef Cattle Vaccine Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Beef Cattle Vaccine Market Size and Prospect (2018-2029)
    • 1.6.6 South America Beef Cattle Vaccine Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Beef Cattle Vaccine Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Biogenesis Bagó
    • 2.1.1 Biogenesis Bagó Details
    • 2.1.2 Biogenesis Bagó Major Business
    • 2.1.3 Biogenesis Bagó Beef Cattle Vaccine Product and Solutions
    • 2.1.4 Biogenesis Bagó Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Biogenesis Bagó Recent Developments and Future Plans
  • 2.2 Indian Immunologicals
    • 2.2.1 Indian Immunologicals Details
    • 2.2.2 Indian Immunologicals Major Business
    • 2.2.3 Indian Immunologicals Beef Cattle Vaccine Product and Solutions
    • 2.2.4 Indian Immunologicals Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Indian Immunologicals Recent Developments and Future Plans
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Beef Cattle Vaccine Product and Solutions
    • 2.3.4 Boehringer Ingelheim Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.4 MSD Animal Health
    • 2.4.1 MSD Animal Health Details
    • 2.4.2 MSD Animal Health Major Business
    • 2.4.3 MSD Animal Health Beef Cattle Vaccine Product and Solutions
    • 2.4.4 MSD Animal Health Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 MSD Animal Health Recent Developments and Future Plans
  • 2.5 CEVA
    • 2.5.1 CEVA Details
    • 2.5.2 CEVA Major Business
    • 2.5.3 CEVA Beef Cattle Vaccine Product and Solutions
    • 2.5.4 CEVA Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 CEVA Recent Developments and Future Plans
  • 2.6 Bayer HealthCare
    • 2.6.1 Bayer HealthCare Details
    • 2.6.2 Bayer HealthCare Major Business
    • 2.6.3 Bayer HealthCare Beef Cattle Vaccine Product and Solutions
    • 2.6.4 Bayer HealthCare Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Bayer HealthCare Recent Developments and Future Plans
  • 2.7 VECOL
    • 2.7.1 VECOL Details
    • 2.7.2 VECOL Major Business
    • 2.7.3 VECOL Beef Cattle Vaccine Product and Solutions
    • 2.7.4 VECOL Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 VECOL Recent Developments and Future Plans
  • 2.8 Brilliant Bio Pharma
    • 2.8.1 Brilliant Bio Pharma Details
    • 2.8.2 Brilliant Bio Pharma Major Business
    • 2.8.3 Brilliant Bio Pharma Beef Cattle Vaccine Product and Solutions
    • 2.8.4 Brilliant Bio Pharma Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Brilliant Bio Pharma Recent Developments and Future Plans
  • 2.9 VETAL
    • 2.9.1 VETAL Details
    • 2.9.2 VETAL Major Business
    • 2.9.3 VETAL Beef Cattle Vaccine Product and Solutions
    • 2.9.4 VETAL Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 VETAL Recent Developments and Future Plans
  • 2.10 BVI
    • 2.10.1 BVI Details
    • 2.10.2 BVI Major Business
    • 2.10.3 BVI Beef Cattle Vaccine Product and Solutions
    • 2.10.4 BVI Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 BVI Recent Developments and Future Plans
  • 2.11 LIMOR
    • 2.11.1 LIMOR Details
    • 2.11.2 LIMOR Major Business
    • 2.11.3 LIMOR Beef Cattle Vaccine Product and Solutions
    • 2.11.4 LIMOR Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 LIMOR Recent Developments and Future Plans
  • 2.12 ME VAC
    • 2.12.1 ME VAC Details
    • 2.12.2 ME VAC Major Business
    • 2.12.3 ME VAC Beef Cattle Vaccine Product and Solutions
    • 2.12.4 ME VAC Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 ME VAC Recent Developments and Future Plans
  • 2.13 Agrovet
    • 2.13.1 Agrovet Details
    • 2.13.2 Agrovet Major Business
    • 2.13.3 Agrovet Beef Cattle Vaccine Product and Solutions
    • 2.13.4 Agrovet Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Agrovet Recent Developments and Future Plans
  • 2.14 Zoetis
    • 2.14.1 Zoetis Details
    • 2.14.2 Zoetis Major Business
    • 2.14.3 Zoetis Beef Cattle Vaccine Product and Solutions
    • 2.14.4 Zoetis Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Zoetis Recent Developments and Future Plans
  • 2.15 Merck
    • 2.15.1 Merck Details
    • 2.15.2 Merck Major Business
    • 2.15.3 Merck Beef Cattle Vaccine Product and Solutions
    • 2.15.4 Merck Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Merck Recent Developments and Future Plans
  • 2.16 GlaxoSmithKline
    • 2.16.1 GlaxoSmithKline Details
    • 2.16.2 GlaxoSmithKline Major Business
    • 2.16.3 GlaxoSmithKline Beef Cattle Vaccine Product and Solutions
    • 2.16.4 GlaxoSmithKline Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.17 Serum Institute of India
    • 2.17.1 Serum Institute of India Details
    • 2.17.2 Serum Institute of India Major Business
    • 2.17.3 Serum Institute of India Beef Cattle Vaccine Product and Solutions
    • 2.17.4 Serum Institute of India Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Serum Institute of India Recent Developments and Future Plans
  • 2.18 Elanco Animal Health
    • 2.18.1 Elanco Animal Health Details
    • 2.18.2 Elanco Animal Health Major Business
    • 2.18.3 Elanco Animal Health Beef Cattle Vaccine Product and Solutions
    • 2.18.4 Elanco Animal Health Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Elanco Animal Health Recent Developments and Future Plans
  • 2.19 Pharmgal Bio
    • 2.19.1 Pharmgal Bio Details
    • 2.19.2 Pharmgal Bio Major Business
    • 2.19.3 Pharmgal Bio Beef Cattle Vaccine Product and Solutions
    • 2.19.4 Pharmgal Bio Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Pharmgal Bio Recent Developments and Future Plans
  • 2.20 Creative Biolabs
    • 2.20.1 Creative Biolabs Details
    • 2.20.2 Creative Biolabs Major Business
    • 2.20.3 Creative Biolabs Beef Cattle Vaccine Product and Solutions
    • 2.20.4 Creative Biolabs Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 Creative Biolabs Recent Developments and Future Plans
  • 2.21 China Agricultural Veterinarian
    • 2.21.1 China Agricultural Veterinarian Details
    • 2.21.2 China Agricultural Veterinarian Major Business
    • 2.21.3 China Agricultural Veterinarian Beef Cattle Vaccine Product and Solutions
    • 2.21.4 China Agricultural Veterinarian Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 China Agricultural Veterinarian Recent Developments and Future Plans
  • 2.22 Yangling Jinhai
    • 2.22.1 Yangling Jinhai Details
    • 2.22.2 Yangling Jinhai Major Business
    • 2.22.3 Yangling Jinhai Beef Cattle Vaccine Product and Solutions
    • 2.22.4 Yangling Jinhai Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.22.5 Yangling Jinhai Recent Developments and Future Plans
  • 2.23 China Animal Husbandry
    • 2.23.1 China Animal Husbandry Details
    • 2.23.2 China Animal Husbandry Major Business
    • 2.23.3 China Animal Husbandry Beef Cattle Vaccine Product and Solutions
    • 2.23.4 China Animal Husbandry Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.23.5 China Animal Husbandry Recent Developments and Future Plans
  • 2.24 Tecon
    • 2.24.1 Tecon Details
    • 2.24.2 Tecon Major Business
    • 2.24.3 Tecon Beef Cattle Vaccine Product and Solutions
    • 2.24.4 Tecon Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.24.5 Tecon Recent Developments and Future Plans
  • 2.25 Bigvet
    • 2.25.1 Bigvet Details
    • 2.25.2 Bigvet Major Business
    • 2.25.3 Bigvet Beef Cattle Vaccine Product and Solutions
    • 2.25.4 Bigvet Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.25.5 Bigvet Recent Developments and Future Plans
  • 2.26 Shen Lian
    • 2.26.1 Shen Lian Details
    • 2.26.2 Shen Lian Major Business
    • 2.26.3 Shen Lian Beef Cattle Vaccine Product and Solutions
    • 2.26.4 Shen Lian Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.26.5 Shen Lian Recent Developments and Future Plans
  • 2.27 Zhongpu
    • 2.27.1 Zhongpu Details
    • 2.27.2 Zhongpu Major Business
    • 2.27.3 Zhongpu Beef Cattle Vaccine Product and Solutions
    • 2.27.4 Zhongpu Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.27.5 Zhongpu Recent Developments and Future Plans
  • 2.28 The Spirit Jinyu
    • 2.28.1 The Spirit Jinyu Details
    • 2.28.2 The Spirit Jinyu Major Business
    • 2.28.3 The Spirit Jinyu Beef Cattle Vaccine Product and Solutions
    • 2.28.4 The Spirit Jinyu Beef Cattle Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.28.5 The Spirit Jinyu Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Beef Cattle Vaccine Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Beef Cattle Vaccine by Company Revenue
    • 3.2.2 Top 3 Beef Cattle Vaccine Players Market Share in 2022
    • 3.2.3 Top 6 Beef Cattle Vaccine Players Market Share in 2022
  • 3.3 Beef Cattle Vaccine Market: Overall Company Footprint Analysis
    • 3.3.1 Beef Cattle Vaccine Market: Region Footprint
    • 3.3.2 Beef Cattle Vaccine Market: Company Product Type Footprint
    • 3.3.3 Beef Cattle Vaccine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Beef Cattle Vaccine Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Beef Cattle Vaccine Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Beef Cattle Vaccine Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Beef Cattle Vaccine Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Beef Cattle Vaccine Consumption Value by Type (2018-2029)
  • 6.2 North America Beef Cattle Vaccine Consumption Value by Application (2018-2029)
  • 6.3 North America Beef Cattle Vaccine Market Size by Country
    • 6.3.1 North America Beef Cattle Vaccine Consumption Value by Country (2018-2029)
    • 6.3.2 United States Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Beef Cattle Vaccine Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Beef Cattle Vaccine Consumption Value by Type (2018-2029)
  • 7.2 Europe Beef Cattle Vaccine Consumption Value by Application (2018-2029)
  • 7.3 Europe Beef Cattle Vaccine Market Size by Country
    • 7.3.1 Europe Beef Cattle Vaccine Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 7.3.3 France Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Beef Cattle Vaccine Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Beef Cattle Vaccine Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Beef Cattle Vaccine Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Beef Cattle Vaccine Market Size by Region
    • 8.3.1 Asia-Pacific Beef Cattle Vaccine Consumption Value by Region (2018-2029)
    • 8.3.2 China Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 8.3.5 India Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Beef Cattle Vaccine Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Beef Cattle Vaccine Consumption Value by Type (2018-2029)
  • 9.2 South America Beef Cattle Vaccine Consumption Value by Application (2018-2029)
  • 9.3 South America Beef Cattle Vaccine Market Size by Country
    • 9.3.1 South America Beef Cattle Vaccine Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Beef Cattle Vaccine Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Beef Cattle Vaccine Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Beef Cattle Vaccine Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Beef Cattle Vaccine Market Size by Country
    • 10.3.1 Middle East & Africa Beef Cattle Vaccine Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Beef Cattle Vaccine Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Beef Cattle Vaccine Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Beef Cattle Vaccine Market Drivers
  • 11.2 Beef Cattle Vaccine Market Restraints
  • 11.3 Beef Cattle Vaccine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Beef Cattle Vaccine Industry Chain
  • 12.2 Beef Cattle Vaccine Upstream Analysis
  • 12.3 Beef Cattle Vaccine Midstream Analysis
  • 12.4 Beef Cattle Vaccine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Beef Cattle Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Beef Cattle Vaccine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Beef Cattle Vaccine market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Beef Cattle Vaccine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Beef Cattle Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Beef Cattle Vaccine market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Beef Cattle Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Beef Cattle Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogenesis Bagó, Indian Immunologicals, Boehringer Ingelheim, MSD Animal Health and CEVA, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Beef Cattle Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Inactivated Foot and Mouth Disease Vaccine
    Bacillus Anthracis Vaccine
    Clostridium Botulinum Vaccine
    Brucella Vaccine
    Pasteurella Vaccine
    Bovine Rotavirus Vaccine
    Others
    Market segment by Application
    Grass Fed Beef Cattle
    Grain-Fed Beef Cattle
    Market segment by players, this report covers
    Biogenesis Bagó
    Indian Immunologicals
    Boehringer Ingelheim
    MSD Animal Health
    CEVA
    Bayer HealthCare
    VECOL
    Brilliant Bio Pharma
    VETAL
    BVI
    LIMOR
    ME VAC
    Agrovet
    Zoetis
    Merck
    GlaxoSmithKline
    Serum Institute of India
    Elanco Animal Health
    Pharmgal Bio
    Creative Biolabs
    China Agricultural Veterinarian
    Yangling Jinhai
    China Animal Husbandry
    Tecon
    Bigvet
    Shen Lian
    Zhongpu
    The Spirit Jinyu
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Beef Cattle Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Beef Cattle Vaccine, with revenue, gross margin and global market share of Beef Cattle Vaccine from 2018 to 2023.
    Chapter 3, the Beef Cattle Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Beef Cattle Vaccine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Beef Cattle Vaccine.
    Chapter 13, to describe Beef Cattle Vaccine research findings and conclusion.

    Buy now